GlassScriptPhysician profile
John C Gorman
NPI 1588670368
$1,598.19
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $963 · 2020: $635.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $403.19 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $236.95 | 2019-2020 | |
| Genzyme Corporation | $179.92 | 2019-2020 | |
| Lilly USA, LLC | $164.69 | 2019-2020 | |
| Celgene Corporation | $135.31 | 2019 | |
| Abbvie INC. | $119.33 | 2019-2020 | |
| Janssen Biotech, INC. | $98.62 | 2020 | |
| Johnson & Johnson Health Care Systems INC. | $79.46 | 2019 | |
| Pfizer INC. | $40.87 | 2019 | |
| Glaxosmithkline, LLC. | $20.74 | 2020 | |
| Ucb, INC. | $20.16 | 2020 | |
| Medexus Pharma, INC. | $19.67 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.89 | 2020 | |
| Hikma Pharmaceuticals USA | $17.58 | 2020 | |
| Genentech USA, INC. | $16.60 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.53 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.68 | 2020 |
2 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Gorman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.